Microfluidic single-cell analysis technology
| Date | Round | Amount |
|---|---|---|
| Apr 2023 | Funding round Vilnius biotech Atrandi Biosciences raised EUR4.5M led by Vsquared Ventures for its single-cell analysis platform. | $4.9M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.